## UNH: UnitedHealth Group Incorporated - XLV: Healthcare

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 4.9% in mid entry zone (3.0-6.0%), top quartile (84th pct) cross-sectional ranking. Short-term MRS_5 (4.7%) confirms momentum alignment. Strong momentum (+6.9% 5-day acceleration). Outperforming sector by 5.2%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($323.64)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. UnitedHealth Group (UNH) Stock News and Forecasts on Dec. 14, 2025: DOJ-Amedisys Deal, Optum Opioid Lawsuit, Earnings Date, and Analyst Targets**
- Source: ts2.tech | 20251214T144652 | Neutral | Relevance: 100%
- UnitedHealth Group (UNH) is navigating significant events including a court-approved DOJ settlement for its Amedisys deal, which requires major divestitures, and a fresh legal challenge from West Virginia targeting Optum over alleged opioid oversupply. The company is also preparing for its full-year 2025 earnings release in January 2026, which will include 2026 guidance, and remains a closely watched healthcare stock with varying analyst targets. Investors are balancing the reduced uncertainty from the Amedisys settlement against new litigation risks and ongoing regulatory scrutiny.

**2. Newbridge Financial Services Group Inc. Purchases 5,641 Shares of UnitedHealth Group Incorporated $UNH**
- Source: MarketBeat | 20251214T120857 | Bullish | Relevance: 100%
- Newbridge Financial Services Group Inc. significantly increased its stake in UnitedHealth Group Incorporated, purchasing an additional 5,641 shares, bringing their total holdings to 6,399 shares valued at $1.996 million. This move contributes to institutional investors owning approximately 87.86% of UNH. UnitedHealth Group also reported strong quarterly earnings, beating EPS estimates, and declared a quarterly dividend of $2.21 per share.

**3. Key facts: UnitedHealth Group earnings release date set; Themes ETFs launches 2X Long UNH Daily ETF**
- Source: TradingView — Track All Markets | 20251214T010508 | Somewhat-Bullish | Relevance: 100%
- UnitedHealth Group (UNH) has announced an upcoming earnings release. Themes ETFs has launched a 2X Long UNH Daily ETF, aiming to double daily returns for UNH, a stock gaining attention due to Warren Buffett's investment.

**4. UnitedHealth Group Announces Earnings Release Date**
- Source: Business Wire | 20251212T210852 | Neutral | Relevance: 100%
- UnitedHealth Group (NYSE: UNH) will release its full year 2025 financial results and provide 2026 financial guidance on Tuesday, January 27, 2026, before the market opens. A teleconference with analysts and investors will follow at 8:00 a.m. ET and will be webcast on the company’s investor relations website. The replay will be available through February 10 on the website.

**5. UnitedHealth Group (UNH) Stock After the Bell on Dec. 11, 2025 – And What to Watch Before the Dec. 12 Open**
- Source: ts2.tech | 20251211T230844 | Neutral | Relevance: 100%
- UnitedHealth Group (UNH) experienced a strong rebound on December 11, 2025, closing up 2.5% at around $336.5, driven by a broad equities rally. Despite a quiet after-hours price, options market activity was robust, with significant put volume suggesting hedging. The article highlights UNH's strategic shifts, including repricing Medicare Advantage plans, portfolio cleanup (like selling Banmedica), and investment in AI, alongside analyst forecasts predicting a "buy" consensus with approximately 20% upside over 12 months, contingent on margin recovery.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 23 ($0.00M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.0% (-0.3%)
- Blackrock Inc.: 8.2% (-1.4%)
- State Street Corpora: 4.9% (-1.8%)
- JPMORGAN CHASE & CO: 4.1% (+85.6%)
- Geode Capital Manage: 2.4% (+2.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +6.9% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.30 suggests fair value with growth premium. Forward P/E 19.2x stretched relative to 9% growth. Balance sheet: $5.1B free cash flow. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $309.7B |
| Beta | 0.43 |
| 52W Range | $234.60 - $606.36 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.30 |
| Forward P/E | 19.2 |
| Current P/E | 20.9 |
| YoY Growth | 8.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -2.1% to 4.9% (+6.9% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 84th percentile. MRS_5 at 4.7% confirms short-term momentum alignment. Outperforming sector by 5.2pp, stock-specific strength. Below SMA200 (0.95x), long-term trend not supportive. MACD histogram positive (2.30), confirming momentum. RSI neutral at 58. OFD pattern: +MUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 4.87% (CS: 84) | Strong |
| RSI_14 | 58.0 | Neutral |
| MACD Histogram | 2.30 | Bullish |
| vs SMA20 | 1.051x | Above |
| vs SMA50 | 1.004x | Above |
| vs SMA200 | 0.953x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $341.84
- **Stop Loss:** $323.64 (5.3% risk)
- **Target:** $369.14 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 54
- **Position Value:** $18,459.36
- **Portfolio %:** 18.46%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-01-15 (Est: $2.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.81 | $2.92 | +4.0% |
| 2025Q2 | $4.45 | $4.08 | -8.2% |
| 2025Q1 | $7.29 | $7.20 | -1.3% |
| 2024Q4 | $6.74 | $6.81 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*